Your browser doesn't support javascript.
loading
Treatment With Anakinra, a Recombinant IL-1 Receptor Antagonist, Unlikely to Induce Lasting Remission in Patients With CGD Colitis.
Hahn, Katherine J; Ho, Nancy; Yockey, Lynne; Kreuzberg, Samantha; Daub, Janine; Rump, Amy; Marciano, Beatriz E; Quezado, Martha; Malech, Harry L; Holland, Steven M; Heller, Theo; Zerbe, Christa S.
Afiliación
  • Hahn KJ; Department of Internal Medicine, Medstar Georgetown University Hospital, Washington, DC, USA.
  • Ho N; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health, Bethesda, Maryland, USA.
  • Yockey L; Laboratory of Clinical Infectious Diseases (LCID), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, Bethesda, Maryland, USA.
  • Kreuzberg S; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health, Bethesda, Maryland, USA.
  • Daub J; Laboratory of Clinical Infectious Diseases (LCID), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, Bethesda, Maryland, USA.
  • Rump A; Laboratory of Clinical Infectious Diseases (LCID), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, Bethesda, Maryland, USA.
  • Marciano BE; Laboratory of Clinical Infectious Diseases (LCID), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, Bethesda, Maryland, USA.
  • Quezado M; National Cancer Institute (NCI), National Institutes of Health, Bethesda, Maryland, USA.
  • Malech HL; Laboratory of Host Defense (LHD), National Institutes of Health, Bethesda, Maryland, USA.
  • Holland SM; Laboratory of Clinical Infectious Diseases (LCID), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, Bethesda, Maryland, USA.
  • Heller T; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health, Bethesda, Maryland, USA.
  • Zerbe CS; Laboratory of Clinical Infectious Diseases (LCID), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, Bethesda, Maryland, USA.
Am J Gastroenterol ; 110(6): 938-9, 2015 Jun.
Article en En | MEDLINE | ID: mdl-26052777

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Colitis / Antirreumáticos / Proteína Antagonista del Receptor de Interleucina 1 / Enfermedad Granulomatosa Crónica Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Límite: Adolescent / Adult / Child / Female / Humans / Male Idioma: En Revista: Am J Gastroenterol Año: 2015 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Colitis / Antirreumáticos / Proteína Antagonista del Receptor de Interleucina 1 / Enfermedad Granulomatosa Crónica Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Límite: Adolescent / Adult / Child / Female / Humans / Male Idioma: En Revista: Am J Gastroenterol Año: 2015 Tipo del documento: Article País de afiliación: Estados Unidos